Shujuan J. Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Fecal microbiome and metabolome dynamics during immunotherapy-based total neoadjuvant therapy in rectal cancer: associations with treatment response and toxicity.

Fecal microbiome and metabolome dynamics during immunotherapy-based total neoadjuvant therapy in rectal cancer: associations with treatment response and toxicity.

Journal: Frontiers in immunology

Published: May 03, 2026

Adjuvant short-course radiotherapy combined with chemotherapy and a PD-1 inhibitor for resected mucosal melanoma: study protocol for a single-arm, prospective, phase II trial.

Adjuvant short-course radiotherapy combined with chemotherapy and a PD-1 inhibitor for resected mucosal melanoma: study protocol for a single-arm, prospective, phase II trial.

Journal: BMJ open

Published: April 16, 2026

Short-Course Radiotherapy Combined With CapeOx and PD-1 Inhibitor Following Local Excision in High-Risk Early Rectal Cancer: Study Protocol for a Prospective Phase II Trial (TORCH-LE).

Short-Course Radiotherapy Combined With CapeOx and PD-1 Inhibitor Following Local Excision in High-Risk Early Rectal Cancer: Study Protocol for a Prospective Phase II Trial (TORCH-LE).

Journal: Clinical Medicine Insights. Oncology

Published: April 10, 2026

Pathological lymph node response after immunotherapy-based total neoadjuvant therapy supports local excision for organ preservation in locally advanced rectal cancer: a propensity-score weighted analysis.

Pathological lymph node response after immunotherapy-based total neoadjuvant therapy supports local excision for organ preservation in locally advanced rectal cancer: a propensity-score weighted analysis.

Journal: Clinical and translational radiation oncology

Published: December 01, 2025

Development and internal validation of a prognostic nomogram for lung metastasis in locally advanced rectal cancer incorporating molecular markers.

Development and internal validation of a prognostic nomogram for lung metastasis in locally advanced rectal cancer incorporating molecular markers.

Journal: Translational cancer research

Published: October 21, 2025

Integration of autophagy-related genes and immune dysregulation reveals a prognostic landscape in multiple myeloma.

Integration of autophagy-related genes and immune dysregulation reveals a prognostic landscape in multiple myeloma.

Journal: Frontiers in oncology

Published: May 26, 2025

The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma.

The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma.

Journal: Therapeutic advances in hematology

Published: April 14, 2025

Comparative evaluation of deep learning-based and conventional reconstruction techniques for image quality enhancement in low-dose chest computed tomography.

Comparative evaluation of deep learning-based and conventional reconstruction techniques for image quality enhancement in low-dose chest computed tomography.

Journal: Journal of thoracic disease

Published: March 19, 2025

Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study.

Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 18, 2025

Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation.

Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation.

Journal: Cancer immunology, immunotherapy : CII

Published: March 10, 2025

Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma.

Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma.

Journal: Frontiers in immunology

Published: January 12, 2025

Development of a cuproptosis-related prognostic signature to reveal heterogeneity of the immune microenvironment and drug sensitivity in acute lymphoblastic leukemia.

Development of a cuproptosis-related prognostic signature to reveal heterogeneity of the immune microenvironment and drug sensitivity in acute lymphoblastic leukemia.

Journal: European journal of medical research

Published: January 08, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026